Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Dow
Express Scripts
Mallinckrodt
McKesson

Last Updated: June 26, 2022

Drug Price Trends for NEVIRAPINE


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for NEVIRAPINE

Average Pharmacy Cost for NEVIRAPINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NEVIRAPINE ER 400 MG TABLET 33342-0238-07 4.29460 EACH 2020-08-19
NEVIRAPINE ER 400 MG TABLET 47781-0317-30 4.29460 EACH 2020-08-19
NEVIRAPINE ER 400 MG TABLET 00378-4890-93 4.29460 EACH 2020-08-19
NEVIRAPINE ER 400 MG TABLET 65862-0933-30 4.29460 EACH 2020-08-19
NEVIRAPINE ER 400 MG TABLET 00781-5893-31 4.29460 EACH 2020-08-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NEVIRAPINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
VIRAMUNE XR 400MG TAB Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0123-30 30 606.36 20.21200 EACH 2022-01-01 - 2022-12-31 FSS
NEVIRAPINE 200MG TAB Golden State Medical Supply, Inc. 60429-0298-60 60 14.15 0.23583 EACH 2018-01-01 - 2022-12-31 FSS
VIRAMUNE 50MG/5ML SUSP,ORAL Boehringer Ingelheim Pharmaceuticals, Inc. 00597-0047-24 240ML 142.44 0.59350 ML 2022-01-01 - 2022-12-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
Mallinckrodt
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.